IL1B and temporal lobe epilepsy: Another magnetic-targeted drug delivery system with superparamagnetic iron oxide NPs and including an anti-interleukin-1β monoclonal antibody (anti-IL-1β mAb) was tested in an acute rat model of temporal lobe epilepsy.